Latest HspE7 Stories
LA JOLLA, Cali., Aug. 22, 2014 /PRNewswire/ -- Research presented at the 29(th) Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc.
NORTH BRUNSWICK, N.J., Feb.
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer.
Among patients with head and neck squamous cell carcinomas, a history of chronic inflammation in the mouth (periodontitis, i.e. gum disease) may be associated with an increased risk of tumors positive for human papillomavirus (HPV).
Virtually all cervical cancers are caused by HPV infections, with just two HPV types, 16 and 18, responsible for about 70 percent of all cases.